Dio Corporation logo

Dio Corporation (039840)

Market Open
7 Aug, 06:30
KRX SM KRX SM
12,570. 00
+160
+1.2893%
231.6B Market Cap
- P/E Ratio
- Div Yield
21,655 Volume
- Eps
12,410
Previous Close
Add Transaction
Day Range
12,290 12,700
Year Range
11,050 19,400
Want to track 039840 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

039840 trading today higher at ₩12,570, an increase of 1.2893% from yesterday's close, completing a monthly increase of 0.56% or ₩70. Over the past 12 months, 039840 stock lost -24.8206%.
039840 is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

039840 Chart

People also search for

Samsung Biologics Co., Ltd.
1,588,000
+1.211%
Celltrion Inc.
204,500
+1.7413%
ALTEOGEN Inc.
340,500
-2.1552%
Sk Biopharmaceuticals Co., Ltd.
90,600
+2.1421%
ABL Bio Inc.
92,300
-1.3889%

Dio Corporation (039840) FAQ

What is the stock price today?

The current price is ₩12,570.00.

On which exchange is it traded?

Dio Corporation is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 039840.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 231.6B.

Has Dio Corporation ever had a stock split?

No, there has never been a stock split.

Dio Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
KRX SM Exchange
KR7039840004 ISIN
KR Country
479 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

DIO Corporation, originating in South Korea and operational internationally, focuses on the manufacture and sale of dental implants. Originally known as DSI Co., Ltd, the company underwent a name change to DIO Corporation in August 2008. Since its inception in 1988, DIO Corporation has expanded its reach beyond its headquarters in Busan, South Korea, to serve a global market. Besides dental implants, the company has diversified its portfolio to include digital dental implant solutions along with dental products and cardiovascular medical devices, reflecting its commitment to innovation in the medical field.

Products and Services

UFII Implant (Internal Submerged and No-Submerged Systems): These are cutting-edge dental implants designed for varying surgical procedures and patient needs. The choice between submerged and no-submerged systems allows for flexibility in treatment plans.

FTN Implant (External Systems): Specifically designed for external use, the FTN implant systems provide alternative solutions for patients, focusing on ease of installation and patient comfort.

Protem Implants: These represent another facet of DIO Corporation's dental implant offerings, designed with the latest technology to ensure high success rates in dental restoration.

UV Active Implant Systems: Utilizing the latest advancements in technology, these implants are treated with a unique process that increases their compatibility with the human body, promoting faster and more effective healing.

Digital Dental Implant Solutions: DIO Corporation embraces the digital transformation in dentistry by providing digital solutions that streamline the implant process, from planning to execution, ensuring precision and improved patient outcomes.

Dental Products: Beyond implants, DIO offers a wide range of products designed to support dental health and procedures, including tools, accessories, and maintenance products.

Cardiovascular Medical Devices: Expanding its expertise beyond dentistry, DIO Corporation also manufactures devices intended for cardiovascular medical support, showcasing its capability in broader medical device innovation.

Contact Information

Address: 66, Centum seo-ro
Phone: 82 51 745 7777